Literature DB >> 10734756

[The practical clinical guidelines of the Sociedad Española de Cardiología on coronary surgery].

J J Alonso1, J Azpitarte, A Bardají, A Cabadés, A Fernández, M Palencia, C Permanyer, E Rodríguez.   

Abstract

Surgery in coronary disease, including myocardial revascularization and the surgery of mechanical complications of acute myocardial infarction, has shown to improve the symptoms, quality of life and/or prognosis in certain groups of patients. The expected benefit in each patient depend on many well-known factors among which the appropriateness of the indication for surgery is fundamental. The objective of these guidelines is to review current indications for cardiac surgery in patients with coronary heart disease through an evaluation of the degree of evidence of effectiveness in the light of current knowledge (systematic review of bibliography) and expert opinion gathered from various reports. Indications and the degree of recommendation for conventional coronary artery bypass grafting have been established for each of the most frequent anatomo-clinical situations defined by clinical symptoms (stable angina, unstable angina and acute myocardial infarction) as well as by left ventricular function and extend of coronary disease. Furthermore, the subgroups with the greatest surgical risk and stratification models are described to aid the decision making process. Also we analyse the rational basis and indication for the new surgical techniques such as minimally invasive coronary surgery and total arterial revascularization. Finally, the indication and timing of surgery in patients with mechanical complications of acute myocardial infarction are considered.

Entities:  

Mesh:

Year:  2000        PMID: 10734756     DOI: 10.1016/s0300-8932(00)75088-3

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  1 in total

1.  Evaluation of the reliability of the EuroSCORE risk analysis prediction in high-risk older patients undergoing CABG.

Authors:  H Iyem
Journal:  Cardiovasc J Afr       Date:  2009 Nov-Dec       Impact factor: 1.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.